Compare ELUT & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELUT | TPCS |
|---|---|---|
| Founded | 2015 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.3M | 39.4M |
| IPO Year | 2020 | 2008 |
| Metric | ELUT | TPCS |
|---|---|---|
| Price | $0.96 | $3.69 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 103.1K | 23.4K |
| Earning Date | 05-08-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 146.77 | 64.20 |
| EPS | N/A | ★ N/A |
| Revenue | $12,293,000.00 | ★ $34,031,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $10.83 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.72 |
| 52 Week Low | $0.50 | $2.88 |
| 52 Week High | $2.60 | $6.25 |
| Indicator | ELUT | TPCS |
|---|---|---|
| Relative Strength Index (RSI) | 42.56 | 41.98 |
| Support Level | $0.86 | $3.40 |
| Resistance Level | $0.99 | $4.01 |
| Average True Range (ATR) | 0.09 | 0.14 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 13.97 | 30.63 |
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.